SCOR announces the creation of a local entity in Brazil, SCOR Brasil Resseguros SA (SCOR Brasil Re), following the licence to operate as a Local Reinsurer granted by the Brazilian insurance authority SUSEP on 26 Augus
SCOR's first half of 2014 results.
SCOR delivers a strong performance for the first half 2014 with net income of EUR 256 million, up 35% from H1 2013
SCOR delivers a strong performance for the first half 2014 with net income of EUR 256 million, up 35% from H1 2013
Details about the liquidity account at 30 june 2014 and of the last half-year statement
NUEVOS ENFOQUES DEL LED (LUPUS ERITEMATOSO DISEMINADO) El lupus es una patología asociada a un pro blema inmunitario.
NUOVI ASPETTI DEL LES (LUPUS ERITEMATOSO SISTEMICO) Il lupus è una patologia legata ad un disturbo immunitario.
Lupus is a disease caused by a disorder of the immune system. Its pathophysiological mechanisms, which include genetic, immunological and environmental factors, remain poorly understood. This is a rare disease.
The Trading Risk Awards ceremony is held each year to acknowledge the hard work and professionalism of the (re)insurance convergence market.
Yesterday evening, the SCOR Group was awarded the “Prix de la meilleure opération financière – M&A” (Prize for the Best Financial Operation) for 2013 by the Club des Trente, for its acquisition of Generali US.
SCOR's first quarter of 2014 results.
All the proposed resolutions were adopted by SCOR’s shareholders by a very large majority, including payment of a dividend of EUR 1.30 per share for the 2013 financial year.
